http://www.idsociety.org/discussion.aspx?g=topics&f=32212256345&groupid=-1 http://www.idsociety.org/discussion.aspx?g=posts&t=32212263169 Started by Jeanna Ray
Last Posted to on Friday, December 28, 2012 11:04:05 AM by JoelFishbain
I agree with your comments. A couple of concerns that I have is the antibiotic options.  amox/clav is fine but many insurance companies including medicaid still won't cover it.  Also to discount cephalosporins (weak, moderate recommendation) and go right to respiratory quinolones seems a bit agressive and as with amox/clav problems with coverage.  If the CAP guidelines from 2007 have not changed for S. pneumo coverage then why the change for ABRS?  I think the doxy is a nice option  for cost and insurance related issues but I would need to review our antibiogram for activity in the current time period against the most common bacterial pathogens.  I would like to see this algorithm reviewed but I agree with you still quite a lack of good scientific data andlimitations with diagnosis. ]]> Fri, 28 Dec 2012 16:04:05 GMT